APA (7th ed.) Citation

K, T., JS, L., YN, W., S, K., AJ, K., A, M., . . . S, A. (2026). A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease. Journal of Parkinson's disease, 16(2), 332. https://doi.org/10.1177/1877718X261418986

Chicago Style (17th ed.) Citation

K, Tosefsky, et al. "A Randomized Safety and Feasibility Crossover Trial of Two Mediterranean-ketogenic Interventions in Individuals with Parkinson's Disease." Journal of Parkinson's Disease 16, no. 2 (2026): 332. https://doi.org/10.1177/1877718X261418986.

MLA (9th ed.) Citation

K, Tosefsky, et al. "A Randomized Safety and Feasibility Crossover Trial of Two Mediterranean-ketogenic Interventions in Individuals with Parkinson's Disease." Journal of Parkinson's Disease, vol. 16, no. 2, 2026, p. 332, https://doi.org/10.1177/1877718X261418986.